Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol as primary therapy for thyrotoxicosis.

E L Mazzaferri, J C Reynolds, R L Young

    Archives of Internal Medicine
    |January 1, 1976
    PubMed
    Summary

    Propranolol hydrochloride alone offers incomplete symptom control for thyrotoxicosis (overactive thyroid). While it improves cardiac function, it is not a sufficient primary treatment for this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Superconducting NbN Resonator Parametric Amplifiers for Millimetre Wavelengths.

    Journal of low temperature physics·2026
    Same author

    Non-degenerate Pumping of Superconducting Resonator Parametric Amplifier with Evidence of Phase-Sensitive Amplification.

    Journal of low temperature physics·2026
    Same author

    Characterizing the optical response of ultra-low-noise far-infrared 60-110 μm transition edge sensors.

    The Review of scientific instruments·2020
    Same author

    Thyroid cancer epidemiology and prognostic variables.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2010
    Same author

    Provision of anaesthesia for porcine cardiac transplantation at the veterinary school in Trinidad and Tobago.

    The West Indian medical journal·2003
    Same author

    A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

    The Journal of clinical endocrinology and metabolism·2003

    Area of Science:

    • Endocrinology
    • Cardiology
    • Pharmacology

    Background:

    • Thyrotoxicosis is associated with increased metabolic rate and cardiovascular effects.
    • Propranolol hydrochloride is a beta-adrenergic blocker with potential applications in managing thyrotoxicosis symptoms.

    Purpose of the Study:

    • To evaluate the efficacy of propranolol hydrochloride monotherapy in treating mild thyrotoxicosis.
    • To assess the impact of propranolol on thyroid function, cardiac performance, and body composition.

    Main Methods:

    • Prospective study of eight patients with mild thyrotoxicosis.
    • Administration of propranolol hydrochloride alone for an average of eight months.
    • Sequential monitoring of thyroid function tests, cardiac systolic time intervals, and body densities.

    Main Results:

    • Two patients achieved euthyroid status; others experienced incomplete symptomatic relief.
    • Weight loss persisted, but lean body mass remained unchanged.
    • Cardiac systolic time intervals showed improvement but did not normalize, indicating persistent augmented myocardial contractility.

    Conclusions:

    • Systolic time intervals are a useful tool for monitoring peripheral response to beta-adrenergic blockade in thyrotoxicosis.
    • Propranolol hydrochloride alone is not recommended as the primary treatment for thyrotoxicosis due to incomplete efficacy.

    Related Experiment Videos